Mark A. Vila

Mark Vila practices at HCA Florida Largo Hospital in Largo, Florida, part of HCA Healthcare.

Mark Vila's NPI, 1073948592, was assigned on September 4, 2013. Mark Vila graduated from PCOM Georgia - Suwanee in 2013. Mark Vila holds Florida license UO3683.

Mark Vila's primary practice is HCA Florida Largo Hospital, at 201 14th St SW, Largo, FL 33770 in Pinellas County. The practice phone is (727) 588-5200.

Mark Vila's primary practice is HCA Florida Largo Hospital in Largo, Florida, part of HCA Healthcare. Mark Vila is also affiliated with Morton Plant Hospital. The medical group on file is Respiratory Specialists. Dmand AI also links Mark Vila to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Vila practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Mark Vila's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Mark Vila is board certified in critical care medicine (caq) by the AOA Board of Internal Medicine. Mark Vila is licensed in Florida.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cellulitis, cerebrovascular disease, chronic diabetes, chronic hypertension and chronic obstructive pulmonary disease (COPD) among the conditions Mark Vila treats.

CMS data shows 1,279 Medicare services from Mark Vila across 11 procedure codes in 2024, for 382 Medicare patients. Medicare paid $146,611 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Mark Vila in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Vila's median patient age at 68, with 45% women.

In 2024, Mark Vila wrote 46 Medicare Part D claims for 21 patients. 59% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $6,750 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Mark Vila for performance year 2024, reported individually. Mark Vila accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Mark Vila in 2019. Mark Vila's most frequent co-authors are Basem Alkurdi, MD, Janyll Irene Castineira, DO and Christopher D. Halleman, DO.

CMS Open Payments shows 100 general payments to Mark Vila from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Inari Medical, Inc. paid the most, $1,010.

Mark Vila graduated from PCOM Georgia - Suwanee in 2013.

Mark Vila is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.